1. Home
  2. FTK vs LXRX Comparison

FTK vs LXRX Comparison

Compare FTK & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flotek Industries Inc.

FTK

Flotek Industries Inc.

HOLD

Current Price

$16.65

Market Cap

522.1M

Sector

Industrials

ML Signal

HOLD

LXRX

Lexicon Pharmaceuticals Inc.

HOLD

Current Price

$1.79

Market Cap

660.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTK
LXRX
Founded
1985
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
522.1M
660.9M
IPO Year
1997
2000

Fundamental Metrics

Financial Performance
Metric
FTK
LXRX
Price
$16.65
$1.79
Analyst Decision
Buy
Strong Buy
Analyst Count
1
2
Target Price
$20.00
$4.15
AVG Volume (30 Days)
211.2K
2.2M
Earning Date
05-05-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
147.06
77.78
EPS
0.84
N/A
Revenue
$136,092,000.00
$49,803,000.00
Revenue This Year
$13.33
N/A
Revenue Next Year
$16.38
N/A
P/E Ratio
$18.65
N/A
Revenue Growth
214.53
60.24
52 Week Low
$6.20
$0.49
52 Week High
$20.41
$1.84

Technical Indicators

Market Signals
Indicator
FTK
LXRX
Relative Strength Index (RSI) 53.72 61.27
Support Level $15.89 $1.07
Resistance Level $17.67 $1.81
Average True Range (ATR) 0.78 0.10
MACD 0.00 0.01
Stochastic Oscillator 66.97 84.29

Price Performance

Historical Comparison
FTK
LXRX

About FTK Flotek Industries Inc.

Flotek Industries Inc is a technology-driven specialty chemistry and data company. It has two reportable segments: Its Chemistry Technologies segment includes specialty chemistries, logistics and technology services. It also include integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies, and international supply chain management companies. The Data Analytics segment provides analytical measurement solutions and deliver real-time information and insights to customers to enable optimization of operations and reduction of emissions and their carbon intensity. Key revenue comes from its Chemistry Technologies segment.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Share on Social Networks: